- Home
- WETH vs GNPX Comparison
WETH vs GNPX Comparison
Compare WETH & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- GNPX
- Stock Information
- Founded
- WETH 1992
- GNPX 2009
- Country
- WETH China
- GNPX United States
- Employees
- WETH N/A
- GNPX N/A
- Industry
- WETH
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- GNPX Health Care
- Exchange
- WETH Nasdaq
- GNPX Nasdaq
- Market Cap
- WETH 10.9M
- GNPX 9.1M
- IPO Year
- WETH N/A
- GNPX 2018
- Fundamental
- Price
- WETH $0.80
- GNPX $0.25
- Analyst Decision
- WETH
- GNPX
- Analyst Count
- WETH 0
- GNPX 0
- Target Price
- WETH N/A
- GNPX N/A
- AVG Volume (30 Days)
- WETH 72.0K
- GNPX 1.1M
- Earning Date
- WETH 08-18-2025
- GNPX 08-12-2025
- Dividend Yield
- WETH N/A
- GNPX N/A
- EPS Growth
- WETH N/A
- GNPX N/A
- EPS
- WETH 0.34
- GNPX N/A
- Revenue
- WETH $41,024,264.00
- GNPX N/A
- Revenue This Year
- WETH N/A
- GNPX N/A
- Revenue Next Year
- WETH N/A
- GNPX N/A
- P/E Ratio
- WETH $2.49
- GNPX N/A
- Revenue Growth
- WETH 2.86
- GNPX N/A
- 52 Week Low
- WETH $0.76
- GNPX $0.20
- 52 Week High
- WETH $2.96
- GNPX $3.97
- Technical
- Relative Strength Index (RSI)
- WETH 39.66
- GNPX 44.26
- Support Level
- WETH $0.82
- GNPX $0.22
- Resistance Level
- WETH $0.97
- GNPX $0.29
- Average True Range (ATR)
- WETH 0.07
- GNPX 0.02
- MACD
- WETH -0.01
- GNPX -0.00
- Stochastic Oscillator
- WETH 16.35
- GNPX 27.78
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.